For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the arrival of Tafamidis and the formulated version represents a genuine breakthrough . These innovative therapies protect the transthyretin protein, slowing its harmful build-up and lessening the severity of the illness. People are now reportin… Read More